SCHEMBL13699707

SCHEMBL13699707

CCN(CC)c1ccc2c(NC(=O)c3cccc(F)c3)c(C(N)=O)oc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2C19 P33261 1/20 0.55
GFER P55789 1/20 0.55
MAPT P10636 12/20 0.52
TP53 P04637 6/20 0.52
HSD17B10 Q99714 5/20 0.52
MAPK10 P53779 3/20 0.52
TSHR P16473 3/20 0.52
AHR P35869 1/20 0.52
HPGD P15428 4/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
NPSR1 Q6W5P4 2/20 0.52
ALDH1A1 P00352 4/20 0.50
LMNA P02545 5/20 0.47
ALOX15 P16050 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699863 0.84 MAPT (0.57) SMN1; SMN2CYP1A2CYP2C19MAPTTP53
SCHEMBL13699693 0.82 TP53 (0.57) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL4257150 0.82 TSHR (0.70) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL13699808 0.81 TP53 (0.64) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL13699874 0.80 MAPT (0.60) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL13699699 0.80 TP53 (0.65) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL13699870 0.79 MAPT (0.53) SMN1; SMN2CYP1A2CYP2C19MAPTTP53
SCHEMBL13699701 0.79 MAPT (0.53) SMN1; SMN2MAPTTP53HSD17B10MAPK10
SCHEMBL13699695 0.78 MAPT (0.57) CYP1A2CYP2C19MAPTTP53HSD17B10
SCHEMBL13699927 0.78 TSHR (0.77) SMN1; SMN2MAPTTP53HSD17B10MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F SMN1; SMN2 2063/4885CYP1A2 495/4885CYP2C19 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.